179 related articles for article (PubMed ID: 7567062)
1. Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens.
Jansen HJ; Grenier D; Van der Hoeven JS
Oral Microbiol Immunol; 1995 Jun; 10(3):138-45. PubMed ID: 7567062
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the use of SDS-PAGE of cell surface extracts and proteolytic activity to differentiate Prevotella nigrescens and Prevotella intermedia.
Cookson AL; Wray A; Handley PS; Jacob AE
FEMS Microbiol Lett; 1996 Feb; 136(2):109-15. PubMed ID: 8869494
[TBL] [Abstract][Full Text] [Related]
3. Protein degradation by Prevotella intermedia and Actinomyces meyeri supports the growth of non-protein-cleaving oral bacteria in serum.
Jansen HJ; van der Hoeven JS
J Clin Periodontol; 1997 May; 24(5):346-53. PubMed ID: 9178115
[TBL] [Abstract][Full Text] [Related]
4. Hydrolytic and depolymerising enzyme activity of Prevotella intermedia and Prevotella nigrescens.
Stubbs S; Lewis MA; Waddington RJ; Embery G
Oral Dis; 1996 Dec; 2(4):272-8. PubMed ID: 9171510
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum.
Frandsen EV; Kjeldsen M; Kilian M
Clin Diagn Lab Immunol; 1997 Jul; 4(4):458-64. PubMed ID: 9220164
[TBL] [Abstract][Full Text] [Related]
6. Proteinase activity of prevotella species associated with oral purulent infection.
Yanagisawa M; Kuriyama T; Williams DW; Nakagawa K; Karasawa T
Curr Microbiol; 2006 May; 52(5):375-8. PubMed ID: 16586023
[TBL] [Abstract][Full Text] [Related]
7. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.
Collin M; Olsén A
Infect Immun; 2001 Nov; 69(11):7187-9. PubMed ID: 11598100
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of Prevotella nigrescens and Prevotella intermedia in infections of endodontic origin.
Bae KS; Baumgartner JC; Shearer TR; David LL
J Endod; 1997 Oct; 23(10):620-3. PubMed ID: 9587274
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of the species Prevotella intermedia and Prevotella nigrescens.
Frandsen EV; Poulsen K; Kilian M
Int J Syst Bacteriol; 1995 Jul; 45(3):429-35. PubMed ID: 8590668
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human immunoglobulin G Fc-binding activity in Prevotella intermedia.
Labbé S; Grenier D
Infect Immun; 1995 Jul; 63(7):2785-9. PubMed ID: 7790101
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucose on formation of cytotoxic end-products and proteolytic activity of Prevotella intermedia, Prevotella nigrescens and Porphyromonas gingivalis.
Saito K; Takahashi N; Horiuchi H; Yamada T
J Periodontal Res; 2001 Dec; 36(6):355-60. PubMed ID: 11762870
[TBL] [Abstract][Full Text] [Related]
12. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and polymerase chain reaction for differentiation of Prevotella intermedia and Prevotella nigrescens.
Baumgartner JC; Bae KS; Xia T; Whitt J; David LL
J Endod; 1999 May; 25(5):324-8. PubMed ID: 10530254
[TBL] [Abstract][Full Text] [Related]
13. In vitro activation of the hemolysin in Prevotella nigrescens ATCC 33563 and Prevotella intermedia ATCC 25611.
Silva TA; Noronha FS; de Macêdo Farias L; Carvalho MA
Res Microbiol; 2004; 155(1):31-8. PubMed ID: 14759706
[TBL] [Abstract][Full Text] [Related]
14. Degradation of immunoglobulin G by periodontal bacteria.
Jansen HJ; van der Hoeven JS; van den Kieboom CW; Göertz JH; Camp PJ; Bakkeren JA
Oral Microbiol Immunol; 1994 Dec; 9(6):345-51. PubMed ID: 7870469
[TBL] [Abstract][Full Text] [Related]
15. Activation of human B-lymphocytes by Prevotella intermedia.
Homayounfar A; Bergström J; Hammarström L
Swed Dent J; 1999; 23(1):11-5. PubMed ID: 10371001
[TBL] [Abstract][Full Text] [Related]
16. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
Grønbaek Frandsen EV
APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
[TBL] [Abstract][Full Text] [Related]
17. Binding and utilization of human transferrin by Prevotella nigrescens.
Duchesne P; Grenier D; Mayrand D
Infect Immun; 1999 Feb; 67(2):576-80. PubMed ID: 9916061
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and genetic characterization of a Prevotella intermedia/nigrescens-like organism.
Könönen E; Mättö J; Väisänen-Tunkelrott ML; Frandsen EV; Helander I; Asikainen S; Finegold SM; Jousimies-Somer H
Int J Syst Bacteriol; 1998 Jan; 48 Pt 1():39-46. PubMed ID: 9542074
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Prevotella intermedia and Prevotella nigrescens by enzyme production, restriction endonuclease and ribosomal RNA gene restriction analyses.
Pearce MA; Dixon RA; Gharbia SE; Shah HN; Devine DA
Oral Microbiol Immunol; 1996 Jun; 11(3):135-41. PubMed ID: 8941766
[TBL] [Abstract][Full Text] [Related]
20. Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure.
Madianos PN; Lieff S; Murtha AP; Boggess KA; Auten RL; Beck JD; Offenbacher S
Ann Periodontol; 2001 Dec; 6(1):175-82. PubMed ID: 11887461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]